After ECMO, Nothing Can Stop Martin
April 26, 2023
At birth, Martin went precious minutes without oxygen. A specialized team at Children’s Hospital Los Angeles raced to save his life—and his brain.
Content related to Online Second Opinion Provides Peace of Mind for Families
‘I Can See! I Can See!’
July 11, 2019
You will have to grant a parental pardon to Heather for her momentary excessive permissiveness, allowing her 5-year-old daughter to race down the block after dark, free from her mother’s hand. It wasn
Upgraded Chemo Propels Luca’s Fight Against Rare Kidney Cancer
September 4, 2024
A more aggressive treatment regimen for clear cell sarcoma has transformed survival rates for children with the disease.
No Longer Night-Blind, Natalia Isn’t Afraid of the Dark
October 19, 2021
After being treated with a breakthrough gene therapy at Children’s Hospital Los Angeles for a genetic eye disorder, 5-year-old Natalia can now see clearly for the first time in her life.
CHLA Researcher to Lead First-Ever International Liquid Biopsy Retinoblastoma Study
August 1, 2023
Study will investigate the use of liquid biopsy for diagnosis and determining disease severity.
After Beating Liver Cancer, Aaroh Gets the Gift of Life
August 29, 2023
Diagnosed with hepatoblastoma at 17 months old, Aaroh is thriving thanks to chemotherapy and a liver transplant—and the experts at Children’s Hospital Los Angeles who gave him life.
Hitting All The Right Notes
September 12, 2023
Born with amniotic band syndrome, Melody is missing some of her fingers and toes. That hasn’t stopped her from embracing her uniqueness and shining in the spotlight.
Looking Ahead: A New Frontier in Retinoblastoma
July 31, 2023
International retinoblastoma research study to begin this summer to investigate liquid biopsy and its use in diagnosing and determining disease severity in retinoblastoma.
Channeling Challenge Into Community: Hunter’s Story
September 10, 2024
Hunter never let his acute lymphoblastic leukemia diagnosis define him—but today, he proudly wears the title “survivor” in support of cancer research.